WO2004017914A3 - Compositions a inhaler - Google Patents

Compositions a inhaler Download PDF

Info

Publication number
WO2004017914A3
WO2004017914A3 PCT/US2003/026385 US0326385W WO2004017914A3 WO 2004017914 A3 WO2004017914 A3 WO 2004017914A3 US 0326385 W US0326385 W US 0326385W WO 2004017914 A3 WO2004017914 A3 WO 2004017914A3
Authority
WO
WIPO (PCT)
Prior art keywords
microns
diameter
less
inhalation composition
lactose particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2003/026385
Other languages
English (en)
Other versions
WO2004017914A2 (fr
WO2004017914A8 (fr
Inventor
Xian-Ming Zeng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Norton Healthcare Ltd
Ivax LLC
Original Assignee
Norton Healthcare Ltd
Ivax LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9942746&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2004017914(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to EP03751884A priority Critical patent/EP1599209B1/fr
Priority to KR1020057002937A priority patent/KR101369631B1/ko
Priority to AT03751884T priority patent/ATE520405T1/de
Application filed by Norton Healthcare Ltd, Ivax LLC filed Critical Norton Healthcare Ltd
Priority to MXPA05001903A priority patent/MXPA05001903A/es
Priority to NZ538965A priority patent/NZ538965A/en
Priority to CA2499273A priority patent/CA2499273C/fr
Priority to BRPI0313647A priority patent/BRPI0313647A2/pt
Priority to JP2004529873A priority patent/JP2006516531A/ja
Priority to AU2003269989A priority patent/AU2003269989B8/en
Priority to EA200500389A priority patent/EA007377B1/ru
Publication of WO2004017914A2 publication Critical patent/WO2004017914A2/fr
Publication of WO2004017914A3 publication Critical patent/WO2004017914A3/fr
Priority to TNP2005000047A priority patent/TNSN05047A1/en
Priority to IL167009A priority patent/IL167009A/en
Anticipated expiration legal-status Critical
Priority to NO20051461A priority patent/NO20051461L/no
Publication of WO2004017914A8 publication Critical patent/WO2004017914A8/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention porte sur une composition à inhaler de poudre sèche contenant des particules de médicament et un mélange de particules de lactose avec diamètre volumétrique moyen compris entre environ 70 et 120 microns et un diamètre inférieur à 250 microns. Le mélange se caractérise par le fait que jusqu'à 96 % en poids des particules de lactose possèdent un diamètre inférieur à 150 microns, 25 % en poids des particules de lactose ont un diamètre inférieur à 5 microns. Ces compositions fournissent une dispersion plus précise, uniforme et régulière lorsqu'elles sont utilisées par exemple avec un inhalateur de poudre sèche. L'invention concerne aussi des procédés d'utilisation des compositions susmentionnées.
PCT/US2003/026385 2002-08-21 2003-08-21 Compositions a inhaler Ceased WO2004017914A2 (fr)

Priority Applications (13)

Application Number Priority Date Filing Date Title
AU2003269989A AU2003269989B8 (en) 2002-08-21 2003-08-21 Inhalation composition
JP2004529873A JP2006516531A (ja) 2002-08-21 2003-08-21 吸入組成物
AT03751884T ATE520405T1 (de) 2002-08-21 2003-08-21 Inhalationszusammensetzung
EA200500389A EA007377B1 (ru) 2002-08-21 2003-08-21 Композиции для ингаляции
MXPA05001903A MXPA05001903A (es) 2002-08-21 2003-08-21 Composicion para inhalacion.
NZ538965A NZ538965A (en) 2002-08-21 2003-08-21 Dry powder inhalation compositions
CA2499273A CA2499273C (fr) 2002-08-21 2003-08-21 Compositions a inhaler
BRPI0313647A BRPI0313647A2 (pt) 2002-08-21 2003-08-21 composições de inalação
KR1020057002937A KR101369631B1 (ko) 2002-08-21 2003-08-21 흡입용 조성물
EP03751884A EP1599209B1 (fr) 2002-08-21 2003-08-21 Compositions a inhaler
TNP2005000047A TNSN05047A1 (en) 2002-08-21 2005-02-18 Inhalation composition
IL167009A IL167009A (en) 2002-08-21 2005-02-21 Dry powder formoterol or its derivatives for inhalation
NO20051461A NO20051461L (no) 2002-08-21 2005-03-18 lnhaleringssammensetning

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB02119513.9 2002-08-21
GB0219513A GB0219513D0 (en) 2002-08-21 2002-08-21 Inhalation compositions including coarse carrier
GB02119513.7 2002-08-21

Publications (3)

Publication Number Publication Date
WO2004017914A2 WO2004017914A2 (fr) 2004-03-04
WO2004017914A3 true WO2004017914A3 (fr) 2004-04-29
WO2004017914A8 WO2004017914A8 (fr) 2005-07-07

Family

ID=9942746

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/026385 Ceased WO2004017914A2 (fr) 2002-08-21 2003-08-21 Compositions a inhaler

Country Status (8)

Country Link
BR (1) BRPI0313647A2 (fr)
CA (1) CA2499273C (fr)
ES (1) ES2371601T3 (fr)
GB (1) GB0219513D0 (fr)
NO (1) NO20051461L (fr)
TN (1) TNSN05047A1 (fr)
WO (1) WO2004017914A2 (fr)
ZA (1) ZA200502177B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007533387A (ja) 2004-04-21 2007-11-22 イノベータ バイオメド リミテッド 吸入器
PL2708225T3 (pl) 2004-04-23 2019-07-31 Cydex Pharmaceuticals, Inc. Formulacja DPI zawierająca eter sulfoalkilowy cyklodekstryny
GB0409197D0 (en) 2004-04-24 2004-05-26 Innovata Biomed Ltd Device
WO2006086270A1 (fr) 2005-02-10 2006-08-17 Glaxo Group Limited Procedes de fabrication du lactose au moyen de techniques de pre-classification et preparations pharmaceutiques ainsi obtenues
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
GB0605723D0 (en) 2006-03-23 2006-05-03 3M Innovative Properties Co Powder filling processes
WO2008134817A1 (fr) * 2007-05-03 2008-11-13 The University Of Sydney Vecteurs composites pour thérapie par inhalation de poudre sèche
TR201205852A2 (tr) * 2011-06-02 2012-12-21 Bi̇lgi̇ç Mahmut Geliştirilmiş yeni kuru toz formülasyonu.
TR201105367A2 (tr) * 2011-06-02 2012-12-21 Bi̇lgi̇ç Mahmut Akış özellikleri geliştirilmiş bir kuru toz formülasyonu.
UA115989C2 (uk) 2012-07-05 2018-01-25 Арвен Айлак Санайі Ве Тіджарет А.С. Фармацевтична композиція для інгалятора сухого порошку, що містить антагоністи мускаринових рецепторів тривалої дії
EP2874928B1 (fr) 2012-07-19 2016-06-15 Adamis Pharmaceuticals Corporation Appareil d'acheminement de poudre
JP6251667B2 (ja) 2014-06-03 2017-12-20 アサヒカルピスウェルネス株式会社 錠剤型即放性製剤及びその製造方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010041164A1 (en) * 1998-12-11 2001-11-15 Volcmar Verkerk Pharmaceutical preparation for inhalation of an opioid
US6645466B1 (en) * 1998-11-13 2003-11-11 Jago Research Ag Dry powder for inhalation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE275391T1 (de) 2000-10-12 2004-09-15 Boehringer Ingelheim Pharma Neue tiotropium-haltige inhalationspulver
UA75375C2 (en) 2000-10-12 2006-04-17 Boehringer Ingelheim Pharma Method for producing powdery preparations for inhaling

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6645466B1 (en) * 1998-11-13 2003-11-11 Jago Research Ag Dry powder for inhalation
US20010041164A1 (en) * 1998-12-11 2001-11-15 Volcmar Verkerk Pharmaceutical preparation for inhalation of an opioid

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1599209A4 *

Also Published As

Publication number Publication date
CA2499273C (fr) 2011-06-21
BRPI0313647A2 (pt) 2019-02-19
TNSN05047A1 (en) 2007-05-14
WO2004017914A2 (fr) 2004-03-04
CA2499273A1 (fr) 2004-03-04
NO20051461L (no) 2005-05-20
GB0219513D0 (en) 2002-10-02
ES2371601T3 (es) 2012-01-05
ZA200502177B (en) 2006-05-31
WO2004017914A8 (fr) 2005-07-07

Similar Documents

Publication Publication Date Title
WO2001095874A3 (fr) Distribution hautement efficace d'une grande quantite d'aerosol therapeutique
WO2004017914A8 (fr) Compositions a inhaler
WO2005079755A3 (fr) Poudres antagonistes de l'interleukine-13, particules sechees par pulverisation, et procedes
EP1599209A4 (fr) Compositions a inhaler
AU2001293899A1 (en) Ihnalation particles incorporating a combination of two or more active ingredients
EP1312357A3 (fr) Formulations pharmaceutiques pour inhalateurs à poudre sèche
AU2001236207A1 (en) Powder formulation
AU2002220857A1 (en) Particles for use in a pharmaceutical composition
HU9503660D0 (en) Compositions for inhalation
CA2395653A1 (fr) Nouvelle poudre a inhaler a teneur en tiotropium
WO2004017918A3 (fr) Procede de preparation de compositions pour inhalation a base de poudres seches
JO2430B1 (en) Pharmaceutical formulas for dry powder inhalations in the form of solid pellets
WO2008051621A3 (fr) Appareil de dispersion de poudre, procédé de fabrication et d'utilisation de l'appareil et composant pouvant être utilisé sur l'appareil et d'autres dispositifs
WO2006002140A3 (fr) Compositions renfermant de l'amphotericine b, procedes et systemes correspondants
AU2001293900A1 (en) Combination particles for the treatment of asthma
AU2003297051A1 (en) Compositions comprising particles containing alumina with compounds bound to the alumina surface, delivery systems and methods of preparation thereof
TW200500066A (en) New tiotropium containing powder formulation for inhalation
TW200730170A (en) Micronised azodicarbonamide, and the preparation and use thereof
WO2002062317A3 (fr) Medicaments
TW200500655A (en) Color filter composition, method and apparatus for manufacturing a color filter having the same
WO2007019723A3 (fr) Complement alimentaire
JO2921B1 (en) Pharmaceutical compound for restricted release of active substances and methods of manufacture

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003751884

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: PA/a/2005/001903

Country of ref document: MX

Ref document number: 1-2005-500326

Country of ref document: PH

WWE Wipo information: entry into national phase

Ref document number: 1020057002937

Country of ref document: KR

Ref document number: 20050058

Country of ref document: UZ

Ref document number: 2004529873

Country of ref document: JP

Ref document number: 167009

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 05023602

Country of ref document: CO

WWE Wipo information: entry into national phase

Ref document number: 2005/02177

Country of ref document: ZA

Ref document number: 996/DELNP/2005

Country of ref document: IN

Ref document number: 200502177

Country of ref document: ZA

WWE Wipo information: entry into national phase

Ref document number: 2499273

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1200500341

Country of ref document: VN

Ref document number: 200500389

Country of ref document: EA

WWE Wipo information: entry into national phase

Ref document number: 2003269989

Country of ref document: AU

Ref document number: 538965

Country of ref document: NZ

Ref document number: 20038224054

Country of ref document: CN

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 10/2004 UNDER (71) (FOR BB ONLY) DELETE "NORTON HEALTHCARE LTD. ¢GB/GB!; ALBERT BASIN, ROYAL DOCKS, LONDON E16 2QJ (GB)."; UNDER (71) (FOR ALL DESIGNATED STATES) ADD "NORTON HEALTHCARE LTD. ¢GB/GB!; ALBERT BASIN, ROYAL DOCKS, LONDON E16 2QJ (GB)."

WWP Wipo information: published in national office

Ref document number: 1020057002937

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2003751884

Country of ref document: EP

ENPW Started to enter national phase and was withdrawn or failed for other reasons

Ref document number: 0313647

Country of ref document: BR

Free format text: PEDIDO RETIRADO FACE A IMPOSSIBILIDADE DE ACEITACAO DA ENTRADA NA FASE NACIONAL POR TER SIDO INTEMPESTIVA. O PRAZO PARA ENTRADA NA FASE NACIONAL EXPIRAVA EM 21.04.2004 (20 MESES - BR DESIGNADO APENAS), ELEICAO NAO COMPROVADA, E A PRETENSA ENTRADA NA FASE NACIONAL SO OCORREU EM 21.02.2005.

ENPZ Former announcement of the withdrawal of the entry into the national phase was wrong

Ref document number: PI0313647

Country of ref document: BR

Free format text: ANULADA A PUBLICACAO CODIGO 1.2 NA RPI NO 1979 DE 09/12/2008, EM ATENDIMENTO A DECISAO RECURSAL PUBLICADA NA RPI NO 2382, DE 30/08/2016.

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: PI0313647

Country of ref document: BR

ENP Entry into the national phase

Ref document number: PI0313647

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20050221